The invention pertains to a non-therapeutic method for improving sleep and/or improving physical activity in a healthy human subject, said method comprising administering to said subject a combination of: i) uridine, or salts, phosphates, acyl derivatives or esters thereof; ii) at least one of docosahexaenoic acid (22:6; DHA) and eicosapentaenoic acid (20:5; EPA), or esters thereof, preferably at least DHA, more preferably DHA and EPA; iii) choline, or salts or esters thereof; and iv) at least one vitamin B selected from vitamins B6, B9 and B12 including their functional equivalents; and v) optionally at least one of vitamin C, vitamin E and selenium.
A61K 31/14 - Composés d'ammonium quaternaire, p. ex. édrophonium, choline
A61K 31/202 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p. ex. acides stéarique, palmitique ou arachidique ayant au moins trois doubles liaisons, p. ex. acide linolénique
A61K 31/519 - PyrimidinesPyrimidines hydrogénées, p. ex. triméthoprime condensées en ortho ou en péri avec des hétérocycles
A61K 31/714 - Cobalamines, p. ex. cyanocobalamine, vitamine B12
A61K 31/7072 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle contenant des pyrimidines condensées ou non-condensées ayant des groupes oxo liés directement au cycle pyrimidine, p. ex. cytidine, acide cytidylique ayant deux groupes oxo liés directement au cycle pyrimidine, p. ex. uridine, acide uridylique, thymidine, zidovudine
2.
METHOD AND DEVICE FOR THE ASSESSMENT OF A NUTRITIONAL COMPOSITION
A method performed by an electronic device assessing a first nutritional composition, obtaining (201, 301, 401) first visual information of the first nutritional composition; determining (202) whether there is a phase separation of the first nutritional composition based on the first visual information; if it is determined that there is a phase separation, determining (203) properties of at least one layer of the phase separation of the first nutritional composition based on the first visual information.
The invention concerns a process for preparing a nutritional composition selected from infant formula, follow-on formula, or young child formula comprising large lipid globules and having low free fat content. The invention further concerns the powdered nutritional composition obtained thereof.
The present invention relates to a process for preparing a nutritional composition comprising the steps of: a) providing an aqueous composition comprising, by weight of said aqueous composition, at least 0.5 wt.% protein and at least 10 wt.% of a carbohydrate; b) providing a lipid composition; c) transferring the aqueous and lipid compositions of steps a) and b) to a combination point for forming a combined composition, wherein the aqueous composition of step a) is transferred to the combination point using a pump; d) mixing the combined composition in a mixing device to provide a mixed composition; e) drying the mixed composition to obtain a dried composition with a total solid of at least 85%, wherein the process does not comprise the use of a pump between step d) and the obtaining of the dried composition of step e). The present invention further relates to an industrial system suitable for carrying out the process according to the invention.
A61K 35/747 - Lactobacilles, p. ex. L. acidophilus ou L. brevis
A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p. ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence
A61K 31/702 - Oligosaccharides, c.-à-d. ayant trois à cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiques
A61K 35/00 - Préparations médicinales contenant des substances ou leurs produits de réaction de constitution non déterminée
A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
A23L 33/135 - Bactéries ou leurs dérivés, p. ex. probiotiques
A23L 33/21 - Adjonction de substances essentiellement non digestibles, p. ex. de fibres diététiques
6.
PROCESS TO PREPARE NUTRITIONAL COMPOSITION WITH LARGE LIPID GLOBULES
The present invention relates to a process for preparing a nutritional composition comprising lipid, protein and digestible carbohydrates, said composition being an infant formula, follow-on formula or growing-up milk, wherein the composition comprises large lipid globules that contain a phospholipids coating.
The invention pertains to nutritional composition comprising non-digestible oligosaccharides [NDOs] selected from i) a mixture of galactooligosaccharides and long-chain fructooligosaccharides and/or ii) a mixture of human milk oligosaccharides comprising at least sialylated, fucosylated and N-acetylated oligosaccharides, for brain injury and/or impaired brain development in infants exposed to perinatal hypoxia and/or preterm infants. The invention further pertains to nutritional compositions comprising a mixture of human milk oligosaccharides comprising at least sialylated, fucosylated and N-acetylated oligosaccharides.
A23L 33/21 - Adjonction de substances essentiellement non digestibles, p. ex. de fibres diététiques
A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
A61K 31/702 - Oligosaccharides, c.-à-d. ayant trois à cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiques
A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux
A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p. ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence
The invention relates to a nutritional composition comprising non-digestible oligosaccharides for infants and/or young children. The invention further relates to the use of said nutritional composition for improving the brain function, in particular social recognition.
The invention relates to a nutritional composition for infants, for children as well as a medical nutritional composition, comprising human milk oligosaccharides and Bifidobacterium breve. The invention further relates to the use of said nutritional composition for strengthening the gut epithelial defense and/or the gut barrier function.
The invention relates to a nutritional composition for infants, children or to a medical nutritional composition. The invention further relates to the use of said nutritional composition for strengthening the gut epithelial defense and/or the gut barrier function.
The present invention relates to a nutritional composition comprising digestible carbohydrates, protein and lipid, wherein the lipid is in the form of larger lipid globules with a coating comprising phospholipids for use in preventing and/or treating intestinal barrier disruption in a human subject.
41 - Éducation, divertissements, activités sportives et culturelles
44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.
Produits et services
Advertising services to promote public awareness and
initiatives; advertising services to promote public
awareness of health issues; advertising services to promote
public awareness of iron deficiency; e-commerce services of
specialized nutrition products, namely food for special
purposes, adapted dietary substances, nutritional products,
vitamin preparations and dietary foods; information and
advice to commercial consumers in the choice of goods and
services; commercial information and advice services for
consumers in the field of nutrition and health. Provision of training and information in the field of
nutrition; education services related to health; educational
services in the healthcare sector; providing training in the
field of health care and nutrition; arranging, organizing
and conducting educational seminars and conference in the
field of nutrition and health; health education and
education services; education services to raise public
awareness for health issues; education services to raise
public awareness for iron deficiency. Provision of advisory services and information in the field
of nutrition; providing health information; providing
information about iron deficiency; advisory, consultancy and
information services in the fields of medicine, health and
nutrition; dietary and nutritional advice; providing
information relating to dietary and nutritional guidance;
providing information relating to dietary and nutritional
guidance for iron deficiency.
13.
NUTRITIONAL COMPOSITION WITH IMPROVED SEGREGATION RESISTANCE
The present invention relates to a powdered nutritional composition comprising (i) milk formula particles comprising lipid, protein, digestible carbohydrates, and (ii) human milk oligosaccharide (HMO) particles, wherein the nutritional composition is selected from an infant, follow-on formula and growing up milk, wherein said nutritional composition is not human milk and wherein the lipid in the milk formula particles is in the form of lipid globules, and
a. the lipid globules have a mode diameter based on volume of at least 1 μm, and/or
b. at least 40 vol. % of the lipid globules have a diameter of 2 to 12 μm
and wherein the HMO particles comprise at least 2′fucosyllactose (2′FL). The invention also relates to a process to prepare the composition and uses thereof.
A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
A23L 33/125 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sirops d'hydrate de carboneModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sucresModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des alcools de sucreModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
The present invention concerns nutritional compositions comprising a mixture of non-digestible oligosaccharides consisting of a combination of 5 specific human milk oligosaccharides, beta-galacto-oligosaccharides and long chain fructo-oligosaccharides (lcFOS). The nutritional compositions are of benefit for improving intestinal microbiota.
A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
A23L 29/00 - Aliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement
A23L 29/30 - Aliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des sirops d'hydrate de carboneAliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des sucresAliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des alcools de sucre, p. ex. du xylitolAliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des hydrolysats d'amidon, p. ex. de la dextrine
A61K 31/702 - Oligosaccharides, c.-à-d. ayant trois à cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiques
A61P 1/00 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif
15.
NUTRITIONAL COMPOSITION FOR TREATING OXIDATIVE STRESS MEDIATED DISORDERS
The invention relates to a nutritional composition for infants, children or a medical nutritional composition and to the use of said nutritional composition for treating and/or preventing oxidative stress mediated disorders.
The present invention relates to a nutritional composition comprising probiotic bacteria wherein the composition comprises lipid in the form of large lipid globules and wherein the lipid globules have a coating comprising phospholipids. The invention further relates to a process for preparing the nutritional composition and to the use of the lipid globules in the nutritional composition for protecting probiotic bacteria against acidic conditions in the stomach and/or for increasing the survival of probiotic bacteria in the gastro-intestinal tract.
The invention provides a method for determining an output anaemia condition, the method comprising: - obtaining a plurality of digital recordings, comprising at least one of the following: - a digital recording comprising static visual information of a subject's finger nails; - a digital recording comprising static visual information of the subject's conjunctiva; - a digital recording comprising static visual information of the subject's oral mucosa; - a digital recording comprising static visual information of the subject's tongue; and the plurality of digital recordings comprising at least - a digital recording comprising temporal visual information of a backlit finger of the subject; - for each of the obtained digital recordings, obtaining a respective anaemia condition assessment using a respective machine learning sub-model that has been trained to detect anaemia conditions in the respective obtained digital recording, - using an ensemble machine learning model to assess an output anaemia condition based on the obtained anaemia condition assessments.
G16H 20/60 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant le contrôle de l’alimentation, p. ex. les régimes
G16H 30/20 - TIC spécialement adaptées au maniement ou au traitement d’images médicales pour le maniement d’images médicales, p. ex. DICOM, HL7 ou PACS
G16H 30/40 - TIC spécialement adaptées au maniement ou au traitement d’images médicales pour le traitement d’images médicales, p. ex. l’édition
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
G16H 50/30 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le calcul des indices de santéTIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour l’évaluation des risques pour la santé d’une personne
G16H 50/70 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour extraire des données médicales, p. ex. pour analyser les cas antérieurs d’autres patients
The invention concerns the specific combination of non-digestible saccharides and lactic acid producing bacteria that was found to be especially suitable for young children, facilitating the most favorable development of the microbiota from an solely breast fed infant-like to an adult-like type taking into account the composition as well as the metabolic activity, on top of that, enabling a high level of butyrate formation, resulting in anti-inflammatory effects and improved gut barrier function.
The invention concerns the specific combination of non-digestible saccharides and lactic acid producing bacteria that was found to be especially suitable for young children, facilitating the most favorable development of the microbiota from an solely breast fed infant-like to an adult-like type taking into account the composition as well as the metabolic activity, on top of that, enabling a high level of butyrate formation, resulting in anti-inflammatory effects and improved gut barrier function.
The invention concerns the specific combination of non-digestible saccharides and lactic acid producing bacteria that was found to be especially suitable for young children, facilitating the most favorable development of the microbiota from an infant-like to an adult-like type taking into account the composition as well as the metabolic activity, and on top of that, advantageously enabling a high level of intestinal butyrate formation.
The invention concerns the specific combination of non-digestible saccharides and lactic acid producing bacteria that was found to be especially suitable for young children, facilitating the most favorable development of the microbiota from an infant-like to an adult-like type taking into account the composition as well as the metabolic activity, on top of that, enabling a high level of butyrate formation, resulting in anti-inflammatory effects and improved gut barrier function.
A nutritional composition comprising digestible carbohydrates, protein and lipid, wherein the lipid is in the form of lipid globules which are at least partly coated on the surface with phospholipids, for improving the gut microbiota and reducing opportunistic pathogens in the gut of human infants.
A61K 31/688 - Diesters d'acide du phosphore avec deux composés hydroxyle, p. ex. phosphatidylinositols les deux composés hydroxylés ayant des atomes d'azote, p. ex. sphingomyélines
A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
A61K 31/20 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p. ex. acides stéarique, palmitique ou arachidique
A61K 31/201 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p. ex. acides stéarique, palmitique ou arachidique ayant une ou deux doubles liaisons, p. ex. acides oléique ou linoléique
A61K 31/202 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p. ex. acides stéarique, palmitique ou arachidique ayant au moins trois doubles liaisons, p. ex. acide linolénique
The invention relates to a nutritional composition comprising non-digestible oligosaccharides, pectin polysaccharides and 2'-fucosyllactose. The invention further relates to the use of the nutritional composition for improving gut health.
The invention concerns the specific combination of non-digestible saccharides and lactic acid producing bacteria that was found to be especially suitable for young children, facilitating the most favorable development of the microbiota from an infant-like to an adult-like type taking into account the composition as well as the metabolic activity, on top of that, enabling a high level of butyrate formation, resulting in anti-inflammatory effects and improved gut barrier function.
The invention concerns the specific mixture of non-digestible saccharides that was found to be especially suitable for young children, facilitating the most favorable development of the microbiota from an infant-like to an adult-like type taking into account the composition as well as the metabolic activity, on top of that, enabling a high level of butyrate formation, resulting in improved gut barrier function.
The invention concerns the specific combination of non-digestible saccharides and lactic acid producing bacteria that was found to be especially suitable for young children, facilitating the most favorable development of the microbiota from an infant-like to an adult-like type taking into account the composition as well as the metabolic activity, and on top of that, advantageously enabling a high level of intestinal butyrate formation.
The invention concerns the specific combination of non-digestible saccharides and lactic acid producing bacteria that was found to be especially suitable for young children, facilitating the most favorable development of the microbiota from an infant-like to an adult-like type taking into account the composition as well as the metabolic activity, and on top of that, advantageously enabling a high level of intestinal butyrate formation.
The invention relates to the use of beta 1,3′-galactosyllactose for ameliorating the harmful effects of food contaminants on the adaptive immune response such as vaccination response or response to a pathogen.
A61K 31/702 - Oligosaccharides, c.-à-d. ayant trois à cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiques
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A61K 47/26 - Hydrates de carbone, p. ex. polyols ou sucres alcoolisés, sucres aminés, acides nucléiques, mono-, di- ou oligosaccharidesLeurs dérivés, p. ex. polysorbates, esters d’acide gras de sorbitan ou glycyrrhizine
A61K 47/42 - ProtéinesPolypeptidesLeurs produits de dégradationLeurs dérivés p. ex. albumine, gélatine ou zéine
A61P 3/02 - Nutriments, p. ex. vitamines, minéraux
A card-based closure for a package suitable for a nutritional product preferably suitable for an infant formula for the type of package comprising a container with an access opening to an interior space for receiving the nutritional product. The closure is arranged for selectively closing the access opening and comprises a lid portion (40) and a hinge assembly, the hinge assembly comprising an inner hinge (71) located at an inside of the package, comprising a flexible strip of card (74) for pivotally connecting the lid portion to a rim of the container.
B65D 43/16 - Couvercles ou chapeaux inamovibles s'ouvrant à charnières vers le haut ou vers le bas
B65D 51/24 - Fermetures non prévues ailleurs combinées avec dispositifs auxiliaires pour des buts autres que la fermeture
B65D 83/06 - Réceptacles ou paquets comportant des moyens particuliers pour distribuer leur contenu pour distribuer un matériau pulvérulent ou granulaire
A card-based closure for a package suitable for a nutritional product preferably suitable for an infant formula for the type of package comprising a container with an access opening to an interior space for receiving the nutritional product. The closure is arranged for selectively closing the access opening and comprises a lid portion and a hinge assembly, the hinge assembly comprising an inner hinge (71) located at an inside of the package, comprising a flexible strip of card (74) for pivotally connecting the lid portion to a rim (30) of the container.
B65D 43/16 - Couvercles ou chapeaux inamovibles s'ouvrant à charnières vers le haut ou vers le bas
B65D 51/24 - Fermetures non prévues ailleurs combinées avec dispositifs auxiliaires pour des buts autres que la fermeture
B65D 83/06 - Réceptacles ou paquets comportant des moyens particuliers pour distribuer leur contenu pour distribuer un matériau pulvérulent ou granulaire
B65D 77/20 - Fermetures des réceptacles formées après remplissage en appliquant des couvercles ou chapeaux séparés
Packages for infant formula are disclosed herein. The packages include a container having an access opening to an interior space, for receiving the infant formula and a closure. Closures for the infant formula package are also disclosed herein. The closures are arranged for selectively closing the access opening and include a lid and a scoop holder located on an underside of the lid to retain a scoop, and the scoop holder has an apertured plate including an apertured portion with an aperture therethrough to receive at least part of the scoop, and both the lid and the scoop holder are formed of card-based material.
A nutritional composition comprising digestible carbohydrates, protein and lipid, wherein the lipid is in the form of lipid globules which are at least partly coated on the surface with phospholipids, for increasing myelination in the brain of an infant who has delayed brain development or is at risk of having delayed brain development.
A23L 33/125 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sirops d'hydrate de carboneModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sucresModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des alcools de sucreModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
NUTRICIA EARLY LIFE NUTRITION ( SHANGHAI ) CO., LTD. (Chine)
Inventeur(s)
Renes, Ingrid Brunhilde
Thomassen, Gabriël
Knol, Jan
Ludwig, Thomas
Jin, Haofang
Abrégé
The present invention relates to compositions comprising lutein, non-digestible carbohydrates and at least one of casein phosphopetides or 1,3-dioleoyl-2-palmitoylglycerol.
A61K 31/231 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine d'acides ayant un groupe carboxyle lié à une chaîne d'au moins sept atomes de carbone ayant une ou deux doubles liaisons
A61K 31/702 - Oligosaccharides, c.-à-d. ayant trois à cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiques
A61K 38/17 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains
A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]
The invention relates to a synbiotic composition comprising Bifidobacterium ssp., non- digestible oligosaccharides, and pectin polysaccharides having a molecular weight between 50-2000 kDa, the backbone thereof comprising at least 55% by weight of the polysaccharide of 1,4-linked a-D-galacturonic acid residues and having a degree of methylation (DM) of at least 35% and/or a pectin polysaccharide that has a degree of polymerisation of at least 260. The invention further relates to a nutritional composition comprising the synbiotic composition. The invention further relates to the use of the synbiotic composition for treating or preventing gut dysbiosis, preferably antibiotic-induced gut dysbiosis.
A card-based package for powdered infant nutrition, comprises a container portion, the container portion defining an interior space for receiving the powdered infant nutrition and having a base and a sidewall extending to an upper peripheral edge for receiving a removable seal for hermetically sealing the container portion prior to use. The package further comprises a collar portion and a lid portion. The collar portion is connected to and extends upwardly from the upper peripheral edge of the container portion and comprises a connection segment and an upper peripheral closure rim surrounding an access opening giving access to the interior space. The lid portion comprises a lid and a frame and forms a re-closable joint with the upper peripheral closure rim of the collar portion, allowing repeated and selective opening and closing of the access opening. The container portion, the collar portion and the lid portion all comprise card-based material.
B65D 77/24 - Garnitures ou accessoires ajoutés ou incorporés durant le remplissage des réceptacles
B65D 81/20 - Réceptacles, éléments d'emballage ou paquets pour contenus présentant des problèmes particuliers de stockage ou de transport ou adaptés pour servir à d'autres fins que l'emballage après avoir été vidés de leur contenu fournissant une ambiance spécifique pour le contenu, p. ex. température supérieure ou inférieure à la température ambiante sous vide ou pression superatmosphérique ou en atmosphère spéciale, p. ex. sous gaz inerte
A card-based package for sensitive food products, comprises a container portion defining an interior space with a base and a sidewall extending to an upper peripheral edge for receiving a removable seal for hermetically sealing the container portion prior to use. The package further comprises a lid structure, that can open and close to allow selective access to the interior space after removal of the seal. The container portion and the lid structure are both formed of card-based material and at least the container portion has light, oxygen, and water vapour barrier properties sufficient for storage of the product for a period exceeding 24 months.
B65D 3/26 - Dispositifs d'ouverture incorporés dans ou fixés aux réceptacles
B65D 3/22 - Réceptacles rigides ou semi-rigides ayant un corps ou des parois périphériques de section transversale courbe ou partiellement courbe, réalisés en enroulant ou courbant du papier sans plier selon des lignes définies avec double paroisRéceptacles rigides ou semi-rigides ayant un corps ou des parois périphériques de section transversale courbe ou partiellement courbe, réalisés en enroulant ou courbant du papier sans plier selon des lignes définies avec des parois incorporant des chambres à airRéceptacles rigides ou semi-rigides ayant un corps ou des parois périphériques de section transversale courbe ou partiellement courbe, réalisés en enroulant ou courbant du papier sans plier selon des lignes définies avec des parois faites en matériau stratifié
B65D 43/16 - Couvercles ou chapeaux inamovibles s'ouvrant à charnières vers le haut ou vers le bas
B65D 51/22 - Capuchons, couvercles ou chapeaux fonctionnant avec une fermeture intérieure disposée pour être ouverte en perçant, coupant ou déchirant comportant des moyens pour percer, couper ou déchirer la fermeture intérieure
B65D 77/24 - Garnitures ou accessoires ajoutés ou incorporés durant le remplissage des réceptacles
B65D 81/20 - Réceptacles, éléments d'emballage ou paquets pour contenus présentant des problèmes particuliers de stockage ou de transport ou adaptés pour servir à d'autres fins que l'emballage après avoir été vidés de leur contenu fournissant une ambiance spécifique pour le contenu, p. ex. température supérieure ou inférieure à la température ambiante sous vide ou pression superatmosphérique ou en atmosphère spéciale, p. ex. sous gaz inerte
B65D 81/30 - Adaptations pour empêcher la détérioration ou l'altération du contenuApplications au réceptacle ou au matériau d'emballage d'agents de conservation des aliments, de fongicides, d'insecticides ou de produits repoussant les animaux en excluant la lumière ou toute autre radiation extérieure
37.
Dietary fiber for treating patients suffering from methylmalonic acidemia and propionic acidemia
The present invention concerns a composition comprising dietary fiber for use in the dietary management of methylmalonic acidemia (MMA) and/or propionic acidemia (PA), and/or for use in treating and/or reducing MMA and/or PA, and/or treating, reducing and/or preventing symptoms associated therewith.
A23L 33/125 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sirops d'hydrate de carboneModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sucresModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des alcools de sucreModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
A23L 33/135 - Bactéries ou leurs dérivés, p. ex. probiotiques
A61K 31/202 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p. ex. acides stéarique, palmitique ou arachidique ayant au moins trois doubles liaisons, p. ex. acide linolénique
A61K 31/59 - Composés contenant le système cyclique du 9,10-séco-cyclopenta[a]hydrophénanthrène
A61K 31/715 - Polysaccharides, c.-à-d. ayant plus de cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiquesLeurs dérivés, p. ex. éthers, esters
A61K 35/747 - Lactobacilles, p. ex. L. acidophilus ou L. brevis
A61P 7/08 - Substitut de plasmaSolutions de perfusionDyalisats ou hémodyalisatsMédicaments pour le traitement des troubles électrolytiques ou acido-basiques, p. ex. choc hypovolémique
A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
A23D 9/00 - Autres huiles ou graisses comestibles, p. ex. huiles pour cuisson
A23L 33/125 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sirops d'hydrate de carboneModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sucresModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des alcools de sucreModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
A23L 33/135 - Bactéries ou leurs dérivés, p. ex. probiotiques
A61K 31/23 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine d'acides ayant un groupe carboxyle lié à une chaîne d'au moins sept atomes de carbone
A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
A61K 31/702 - Oligosaccharides, c.-à-d. ayant trois à cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiques
A61K 35/00 - Préparations médicinales contenant des substances ou leurs produits de réaction de constitution non déterminée
A61K 35/747 - Lactobacilles, p. ex. L. acidophilus ou L. brevis
A61K 38/17 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains
A61K 38/40 - Transferrines, p. ex. lactoferrines, ovotransferrines
The invention provides a computer implemented method of analysing at least one excreta, comprising the steps of; - receiving a first visual information of a first excreta of a first subject; identifying at least one region of interest within the first visual information; - applying a trained machine learning model to the identified at least one region of interest in order to identify characteristics of the first excreta; and determining a microbiome profile of the first excreta based on the identified characteristics of the first excreta, wherein said characteristics comprise at least one of colour, consistency, and texture. The invention further provides a non-transitory computer readable medium and a system for analysing at least one excreta.
G16H 30/40 - TIC spécialement adaptées au maniement ou au traitement d’images médicales pour le traitement d’images médicales, p. ex. l’édition
C12Q 1/04 - Détermination de la présence ou du type de micro-organismeEmploi de milieux sélectifs pour tester des antibiotiques ou des bactéricidesCompositions à cet effet contenant un indicateur chimique
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
A61B 10/00 - Instruments pour le prélèvement d'échantillons corporels à des fins de diagnostic Autres procédés ou instruments pour le diagnostic, p. ex. pour le diagnostic de vaccination ou la détermination du sexe ou de la période d'ovulationInstruments pour gratter la gorge
G01N 33/493 - Analyse physique de matériau biologique de matériau biologique liquide d'urine
G16H 20/60 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant le contrôle de l’alimentation, p. ex. les régimes
G06V 10/54 - Extraction de caractéristiques d’images ou de vidéos relative à la texture
G06V 10/56 - Extraction de caractéristiques d’images ou de vidéos relative à la couleur
41.
Nutrition Digestive Efficacy Assistant and computer implemented algorithm thereof
NUTRICIA EARLY LIFE NUTRITION (SHANGHAI) CO., LTD. (Chine)
Inventeur(s)
Ward, Gregg
Liu, Mengjin
Guo, Bingzhi
Jin, Yi
Zheng, Yixiao
Hu, Jinhui
Foussat, Agathe Camille
Song, Jiahang
Ludwig, Thomas
Abrégé
A computer-implemented method of analyzing excreta, comprising: obtaining visual information of excreta, providing the visual information to an artificial intelligence (AI) model; processing the visual information using the AI model to determine a plurality of scales of the excreta; outputting the plurality of scales of the excreta, receiving at least one input to adjust the plurality of scales of the excreta, and providing suggestion based on the adjusted plurality of scales of the excreta.
A process of preparing a shelf-stable liquid enteral nutritional composition, said process comprising the steps of providing an oil-in-water emulsion, sterilizing the emulsion by direct steam injection (DSI) to obtain a sterilized emulsion with a F0 value of at least 3 and subjecting the sterilized emulsion to high pressure homogenization.
A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
A23C 9/152 - Préparations à base de laitLait en poudre ou préparations à base de lait en poudre comportant des additifs
A23J 1/20 - Préparation des compositions à base de protéines pour l'alimentationOuverture des œufs par grandes quantités et séparation du jaune du blanc à partir du lait, p. ex. caséinePréparation des compositions à base de protéines pour l'alimentationOuverture des œufs par grandes quantités et séparation du jaune du blanc à partir du petit-lait
A23L 33/115 - Acides gras ou leurs dérivésGraisses ou huiles
A23L 33/125 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sirops d'hydrate de carboneModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sucresModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des alcools de sucreModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
43.
Multi fiber composition with improved fermentation
The invention pertains to a fiber mixture comprising arabinoxylan, beta-glucan, pectin, and resistant starch, nutritional compositions comprising the fiber mixture and uses thereof. The fiber mixture comprising is beneficially used in improving intestinal health and/or preventing impaired intestinal health.
The invention relates to a particulate nutritional composition for infants with less powder segregation, wherein the particulate nutritional composition comprises milk formula particles and probiotic particles, which differ in particle size. The invention further relates to a process for producing the particulate nutritional composition and to a use of the particulate nutritional composition.
NUTRICIA EARLY LIFE NUTRITION (SHANGHAI) CO., LTD. (Chine)
Inventeur(s)
Renes, Ingrid Brunhilde
Thomassen, Gabriël
Knol, Jan
Ludwig, Thomas
Jin, Haofang
Abrégé
The present invention lies on the field of synergistic compositions for improving mineral bioaccessibility, in particular iron and/or calcium bioaccessibility. The synergistic compositions comprise lutein, casein phosphopeptide or 1,3-dioleoyl-2-palmitoylglycerol, preferably in combination with a non-digestible carbohydrate. The invention further relates to the use of the compositions in preventing and/or treating mineral deficiency and associated conditions, preferably anaemia.
A61K 31/047 - Composés hydroxylés, p. ex. alcoolsLeurs sels, p. ex. alcoolates ayant plusieurs groupes hydroxyle, p. ex. sorbitol
A61K 31/231 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine d'acides ayant un groupe carboxyle lié à une chaîne d'au moins sept atomes de carbone ayant une ou deux doubles liaisons
A61K 31/702 - Oligosaccharides, c.-à-d. ayant trois à cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiques
A61K 33/06 - Aluminium, calcium ou magnésiumLeurs composés
A61K 38/17 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains
A61P 3/02 - Nutriments, p. ex. vitamines, minéraux
46.
LUTEIN FOR USE IN INHIBITING MAST CELL DEGRANULATION
NUTRICIA EARLY LIFE NUTRITION (SHANGHAI) CO., LTD. (Chine)
Inventeur(s)
Knipping, Catharina Theresia
Garssen, Johan
Ludwig, Thomas
Buurman, Nicole
Jin, Haofang
Abrégé
The present invention relates to nutritional compositions comprising lutein for inhibiting mast cell degranulation, thereby preventing or treating symptoms or disorders associated with mast cell degranulation. Preferably, the compositions comprise lutein and non-digestible carbohydrates, such as those selected from prebiotic oligosaccharides, human oligosaccharides and combinations thereof.
A61K 31/047 - Composés hydroxylés, p. ex. alcoolsLeurs sels, p. ex. alcoolates ayant plusieurs groupes hydroxyle, p. ex. sorbitol
A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
A61K 31/231 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine d'acides ayant un groupe carboxyle lié à une chaîne d'au moins sept atomes de carbone ayant une ou deux doubles liaisons
A61K 31/7016 - Disaccharides, p. ex. lactose, lactulose
A61K 31/702 - Oligosaccharides, c.-à-d. ayant trois à cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiques
A61K 38/17 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains
47.
LUTEIN AND 1,3-DIOLEOYL-2-PALMITOYL GLYCEROL FOR USE IN THE PREVENTION OR TREATMENT OF A DISORDER OF THE GASTROINTESTINAL TRACT
The present invention relates to an oat base with improved health-beneficial properties. The invention also provides for uses of the oat base or a composition comprising the oat base for increasing intestinal short chain fatty acid and/or L-lactate production and/or reducing intestinal gas production and/or modulating the gut microbiota in a subject, as well as health benefits associated with increased intestinal acetate and/or L-lactate production.
A23C 11/10 - Succédanés du lait, p. ex. compositions pour remplacer le lait dans le café au lait contenant au moins un composé d'origine non laitière comme source de matières grasses ou de protéines contenant ou non du lactose mais pas d'autres composés d'origine laitière comme sources de matières grasses, d'hydrates de carbone ou de protéines
The present invention relates to a liquid cereal base. The invention also provides a method for obtaining the liquid cereal base and uses thereof as ingredient of plant-based food and beverage products.
A23C 11/10 - Succédanés du lait, p. ex. compositions pour remplacer le lait dans le café au lait contenant au moins un composé d'origine non laitière comme source de matières grasses ou de protéines contenant ou non du lactose mais pas d'autres composés d'origine laitière comme sources de matières grasses, d'hydrates de carbone ou de protéines
09 - Appareils et instruments scientifiques et électriques
38 - Services de télécommunications
41 - Éducation, divertissements, activités sportives et culturelles
42 - Services scientifiques, technologiques et industriels, recherche et conception
44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.
Produits et services
Downloadable computer software program for computer networking; Downloadable graphical user interface software; Downloadable mobile operating system software; Downloadable computer software for word processing; Downloadable educational software for providing information and educational information, online educational information in the fields of specialized nutrition, medical nutrition, medical research, scientific research, biological science, digital health, genomes, genetics, genetic screening, pharmaceutical preparation, nutrition, diet, beauty arts, body work therapy, food and dietary supplements, health nutrition, medical training, teaching, arranging and conducting of workshops, and for training others in all of the foregoing; Recorded computer software for accessing, reading, and tracking information in the fields of specialized nutrition, medical nutrition, medical research, scientific research, biological science, digital health, genomes, genetics, genetic screening, pharmaceutical preparation, nutrition, diet, beauty arts, body work therapy, food and dietary supplements, health nutrition, medical training, teaching, arranging and conducting of workshops, and for training others in all of the foregoing; Downloadable computer software applications for accessing, reading, and tracking information in the fields of specialized nutrition, medical nutrition, medical research, scientific research, biological science, digital health, genomes, genetics, genetic screening, pharmaceutical preparation, nutrition, diet, beauty arts, body work therapy, food and dietary supplements, health nutrition, medical training, teaching, arranging and conducting of workshops, and for training others in all of the foregoing; downloadable software in the nature of a mobile application for accessing, reading, and tracking information in the fields of specialized nutrition, medical nutrition, medical research, scientific research, biological science, digital health, genomes, genetics, genetic screening, pharmaceutical preparation, nutrition, diet, beauty arts, body work therapy, food and dietary supplements, health nutrition, medical training, teaching, arranging and conducting of workshops, and for training others in all of the foregoing Providing online educational forums in the fields of specialized nutrition, medical nutrition, medical research, scientific research, biological science, digital health, genomes, genetics, genetic screening, pharmaceutical preparation, nutrition, diet, beauty arts, body work therapy, food and dietary supplements, health nutrition, medical training, teaching, arranging and conducting of workshops, and for training others in all of the foregoing Educational services, namely, providing information on-line relating to educational opportunities; Educational services namely providing conferences, in-person forums, workshops, and online information on education all in the field of specialized nutrition, medical nutrition, medical research, scientific research, biological science, digital health, genomes, genetics, genetic screening, pharmaceutical preparation, nutrition, diet, beauty arts, body work therapy, food and dietary supplements, health nutrition, medical training, teaching, arranging and conducting of workshops, and for training others in all of the foregoing; Providing information on education in the fields of specialized nutrition, medical nutrition, medical research, scientific research, biological science, digital health, genomes, genetics, genetic screening, pharmaceutical preparation, nutrition, diet, beauty arts, body work therapy, food and dietary supplements, health nutrition, medical training, teaching, arranging and conducting of workshops, and for training others in all of the foregoing; Providing information about online education; Arranging and conducting of in-person educational forums in the field of specialized nutrition, medical nutrition, medical research, scientific research, biological science, digital health, genomes, genetics, genetic screening, pharmaceutical preparation, nutrition, diet, beauty arts, body work therapy, food and dietary supplements, health nutrition, medical training, teaching, arranging and conducting of workshops, and for training others in all of the foregoing; Arranging and conducting of educational conferences in the field of specialized nutrition, medical nutrition, medical research, scientific research, biological science, digital health, genomes, genetics, genetic screening, pharmaceutical preparation, nutrition, diet, beauty arts, body work therapy, food and dietary supplements, health nutrition, medical training, teaching, arranging and conducting of workshops, and for training others in all of the foregoing; Bodywork therapy instruction; Beauty arts instruction; medical training and teaching; arranging and conducting of workshops in the field of specialized nutrition, medical nutrition, medical research, scientific research, biological science, digital health, genomes, genetics, genetic screening, pharmaceutical preparation, nutrition, diet, beauty arts, body work therapy, food and dietary supplements, health nutrition, medical training, teaching, arranging and conducting of workshops, and for training others in all of the foregoing; Educational services, namely, providing instruction in the field of specialized nutrition, medical nutrition, medical research, scientific research, biological science, digital health, genomes, genetics, genetic screening, pharmaceutical preparation, nutrition, diet, beauty arts, body work therapy, food and dietary supplements, health nutrition, medical training, teaching, arranging and conducting of workshops, and for training others in all of the foregoing Scientific research and development; scientific research; research in the field of food; medical research; Technical consulting services in the field of food and dietary supplements; Technical consulting services in the field of diet; research and development of new products; research and development of new products for others; development of pharmaceutical preparations and pharmaceuticals; genetic screening for scientific research purposes; biological research; biological research and analysis; structural and functional analysis of genomes; biomedical research services Health care; medical information; Advisory services relating to nutrition; Food nutrition consultation; Consulting services in the field of nutrition; medical consultations; medical services; medical screening; medical analysis services for diagnostic and treatment purposes provided by medical laboratories
52.
PROVIDING NUTRITIONAL FORMULA TO A SUBJECT ADHERING TO A KETOGENIC DIET
The invention pertains to a substantially gluten-free ketogenic flour blend having a ketogenic weight ratio between 2.3:1 and 2.9:1, preferably between 2.4:1 and 2.9:1, the blend comprising between 50 and 70 gram lipid per 100 g dry weight, comprising at least one, more preferably at least two, most preferably all of: (a) between 15 and 20 g MCT/100 g dry weight; (b) MCT providing 20 – 30% of the total energy content of the blend; (c) between 20 and 35 wt% MCT based on total weight of the lipid, and further comprising at least 2.5 g/100 g dry weight of fructo-oligosaccharides (FOS) and/or galacto- oligosaccharides (GOS), preferably FOS.
A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p. ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence
The invention pertains to a synthetic mixture of human milk oligosaccharides (HMOs) wherein the mixture comprises 10 – 30 wt% acidic HMOs and 70 – 90 wt% neutral HMOs, wherein the neutral HMOs comprises 75 – 95 wt% of fucosylated HMOs based on weight of the neutral HMOs and wherein the mixture comprises at least 19 HMOs.
The invention pertains to a synthetic mixture of human milk oligosaccharides (HMOs) comprising 10 – 30 wt% acidic HMOs and 70 – 90 wt% neutral HMOs, wherein the neutral HMOs comprises 75 – 95 wt% of fucosylated HMOs based on weight of the neutral HMOs, and use of the mixture of HMOs in the treatment and/or prevention of infections.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
(1) Food for special medical purposes; dietetic foods and substances adapted for medical purposes; food for babies; food for patients and sick persons; infant formula; food for babies with special nutritional needs; non-dairy and plant-based milks for babies, namely milks derived from plants, vegetables, cereals, grains, nuts, seeds, beans and fruits; nutritional products for medical purposes; nutritional supplements; cereals for infants; vitamin preparations; dietetic foods for pregnant, lactating and breast feeding women; dietetic milk for pregnant, lactating and breast feeding women; dietary fiber; protein dietary supplements; soy protein dietary supplements; protein supplements shakes; energy bars used as food supplements; dietary supplements for human beings
The invention relates to nutritional compositions comprising a mixture of non-digestible oligosaccharides comprising short-chain fructo-oligosaccharides, long-chain fructo-oligosaccharides and 2'-fucosyllactose that have been shown to provide a beneficial short-chain fatty acids profile and intestinal bifidobacteria population. The nutritional compositions are for infants and young children and are in particular beneficial for infants or young children suffering from food allergy, in particular cow's milk protein allergy.
A23L 33/21 - Adjonction de substances essentiellement non digestibles, p. ex. de fibres diététiques
A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
A61K 31/702 - Oligosaccharides, c.-à-d. ayant trois à cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiques
A61K 31/715 - Polysaccharides, c.-à-d. ayant plus de cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiquesLeurs dérivés, p. ex. éthers, esters
30 - Aliments de base, thé, café, pâtisseries et confiseries
Produits et services
(Based on 44(e))(Based on Intent to Use) Cereals, processed; Cereals prepared for human consumption; Breakfast cereals; Processed cereal-based food to be used as a breakfast food, snack food or ingredient for making other foods; Cereal bars; Cereal-based snack foods; High-protein cereal bars; Cereal based energy bars (Based on Intent to Use) Muesli; Rice-based snack foods; Biscuits; Cakes; Pastries; Sugar; Confectionery made of sugar; Candy; Dessert mousses; Pancakes; Waffles; Chocolate; Cocoa-based beverages; Chocolate-based beverages containing milk; Chocolate-based drinks; Coffee-based beverages; Tea-based beverages; Custard; Ice cream; Edible ices; Fruit coulis; Chocolate-based spreads; Chocolate-based spreads also containing nuts; Sherbets; Confectionery ices
58.
O/W COMPOSITION EMULSIFIED WITH OSA STARCH FOR USE IN GLYCOGEN STORAGE DISEASE
The invention relates to an emulsified O/W composition comprising emulsified lipid and OSA starch wherein the dry weight ratio of OSA starch to lipid is in the range from 1:3 to 1:5 and wherein less than 4 wt% protein is present based on total dry weight of the emulsified O/W composition and relates to the nutritional composition comprising the emulsified O/W composition and to the method of making these compositions and further relates to a nutritional composition for use in glycogen storage disease.
A23L 29/212 - AmidonAmidon modifiéDérivés d'amidon, p. ex. esters ou éthers
A23L 33/115 - Acides gras ou leurs dérivésGraisses ou huiles
A23L 33/125 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sirops d'hydrate de carboneModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sucresModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des alcools de sucreModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
The invention relates a nutritional compositions comprising lipid, OSA starch, protein, an encapsulating agent and carbohydrates, wherein the composition comprises lipid-containing particles which have a lipid core and wherein said lipid core is coated with OSA starch, and wherein the lipid core and OSA starch coating comprise less than 4 wt% protein altogether and relates to the method of making the nutritional compositions and further relates to the nutritional composition for use in glycogen storage disease.
A23L 29/212 - AmidonAmidon modifiéDérivés d'amidon, p. ex. esters ou éthers
A23L 33/115 - Acides gras ou leurs dérivésGraisses ou huiles
A23L 33/125 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sirops d'hydrate de carboneModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sucresModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des alcools de sucreModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
The invention pertains to nutritional compositions and uses thereof comprising digestible carbohydrates, lipids, protein, 3-fucosyllactose (3-FL) and a source of butyrate suitable for providing nutrition to an infant or young child suffering from or at risk of developing a food allergy, preferably cow's milk protein or hen's egg allergy, wherein the protein is or essentially consists of hydrolysed protein and/or free amino acids and wherein the butyrate is provided in the form of dietary butyrate and/or by non-digestible saccharides selected non-digestible polysaccharides, non-digestible oligosaccharides or mixtures thereof capable of undergoing microbial fermentation in the gastrointestinal tract to produce butyrate.
A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
A61K 31/715 - Polysaccharides, c.-à-d. ayant plus de cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiquesLeurs dérivés, p. ex. éthers, esters
A23L 33/21 - Adjonction de substances essentiellement non digestibles, p. ex. de fibres diététiques
A23L 33/115 - Acides gras ou leurs dérivésGraisses ou huiles
A61K 31/702 - Oligosaccharides, c.-à-d. ayant trois à cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiques
05 - Produits pharmaceutiques, vétérinaires et hygièniques
29 - Viande, produits laitiers et aliments préparés ou conservés
Produits et services
Food supplements; Wheat-free and gluten-free food for the treatment of special medical and health conditions; Dietetic foods adapted for medical purposes; Food for babies; Dietetic foods and beverages adapted for medical use; Infant formula; Liquid formula milk for infants; Powdered milk for babies; Dietetic foods, namely, plant-based milk substitutes adapted for medical use; Dietetic foods, namely, non-dairy and plant-based milks for babies, namely milks derived from plants, vegetables, cereals, grains, nuts, seeds, beans and fruits adapted for medical use; Nutritional food additives for medical purposes in the nature of natural food extracts derived from plants, vegetables, cereals, grains, nuts, seeds, beans and fruits; Nutritionally fortified beverages for medical purposes; Nutritional supplements; Vitamin and mineral supplements for mixing with cereals for infants; Vitamin preparations; Dietetic foods, namely, foods and beverages for pregnant, lactating and breast feeding women adapted for medical use; Dietetic foods, namely, milk for pregnant, lactating and breast feeding women adapted for medical use; Dietary fiber to aid digestion; Protein dietary supplements; Soy protein dietary supplements; Protein supplement shakes; Nutritional supplement energy bars; Natural dietary supplements; Probiotic preparations for medical use; Delivery agents in the form of food for babies with special nutritional needs that facilitate the delivery of nutritional supplements; Delivery agents in the form of milk for babies with special nutritional needs that facilitate the delivery of nutritional supplements Milk; Milk products excluding ice cream, ice milk and frozen yogurt; Yogurt; Milk substitutes; Plant-based milk substitutes; Cottage cheese; Milk beverages with high milk content; Compotes; Fruit-based snack food; Nut-based snack bars; Seed-based snack bars; Organic nut and seed-based snack bars; Powdered milk; frozen, prepared, dried, preserved or packaged meals consisting primarily of meat, fish, poultry or vegetables; Meat, fish, poultry and game, not live; Meat, fish, fruit and vegetable preserves; Yogurt-based snack foods; Fruit purees
05 - Produits pharmaceutiques, vétérinaires et hygièniques
29 - Viande, produits laitiers et aliments préparés ou conservés
Produits et services
Food supplements; Wheat-free and gluten-free food for the treatment of special medical and health conditions; Dietetic foods adapted for medical purposes; Food for babies; Dietetic foods and beverages adapted for medical use; Infant formula; Powdered milk for babies; Dietetic foods, namely, plant-based milk substitutes adapted for medical use; Dietetic foods, namely, non-dairy and plant-based milks for babies, namely milks derived from plants, vegetables, cereals, grains, nuts, seeds, beans and fruits adapted for medical use; Nutritionally fortified beverages for medical purposes; Nutritional supplements; Vitamin and mineral supplements for mixing with cereals for infants; Vitamin preparations; Protein dietary supplements; Natural dietary supplements; Probiotic preparations for medical use; Delivery agents in the form of food for babies with special nutritional needs that facilitate the delivery of nutritional supplements; Delivery agents in the form of milk for babies with special nutritional needs that facilitate the delivery of nutritional supplements Milk; Milk products excluding ice cream, ice milk and frozen yogurt; Yogurt; Milk substitutes; Plant-based milk substitutes; Milk beverages with high milk content; Powdered milk
Nutricia Early Life Nutrition (Shanghai) Co., Ltd. (Chine)
Inventeur(s)
Wopereis, Harm Johannes
Roeselers, Guus
Liu, Mengjin
Jin, Yi
Abrégé
The invention pertains to a composition for use in increasing the relative abundance of Bacteroides and Parabacteroides in the intestinal microbiota of an infant that was delivered by Caesarean section or of an infant that was exposed to antibiotics early in life (e.g. intrapartum antibiotic prophylaxis (IAP)), preferably an infant that was delivered by Caesarean section, wherein the composition comprises Bifidobacterium breve and non-digestible oligosaccharide(s).
A23L 33/135 - Bactéries ou leurs dérivés, p. ex. probiotiques
A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
A23L 33/125 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sirops d'hydrate de carboneModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sucresModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des alcools de sucreModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
The present invention relates to a process of producing a demineralised vitamin-reduced lactose concentrate, said process comprising the step of contacting a partially demineralised aqueous lactose isolate with an ion-exchange resin. The present invention further relates to a demineralised vitamin-reduced lactose concentrate.
A23C 9/14 - Préparations à base de laitLait en poudre ou préparations à base de lait en poudre dans lesquelles la composition chimique du lait est modifiée par des traitements non chimiques
A23C 9/142 - Préparations à base de laitLait en poudre ou préparations à base de lait en poudre dans lesquelles la composition chimique du lait est modifiée par des traitements non chimiques par dialyse, osmose inverse ou ultrafiltration
05 - Produits pharmaceutiques, vétérinaires et hygièniques
29 - Viande, produits laitiers et aliments préparés ou conservés
30 - Aliments de base, thé, café, pâtisseries et confiseries
Produits et services
(1) Food for special medical purposes; dietetic foods and substances adapted for medical purposes; food for babies; food for patients and sick persons; infant formula; food for babies with special nutritional needs; non-dairy and plant-based milks for babies, namely milks derived from plants, vegetables, cereals, grains, nuts, seeds, beans and fruits; nutritional products for medical purposes; nutritional supplements; cereals for infants; vitamin preparations; dietetic foods for pregnant, lactating and breast feeding women; dietetic milk for pregnant, lactating and breast feeding women; dietary fiber; protein dietary supplements; soy protein dietary supplements; protein supplements shakes; energy bars used as food supplements; dietary supplements for human beings
(2) Milk and milk products ; yogurt ; milk substitutes ; plant-based milk and milk products, namely milks derived from plants, vegetables, grains, nuts, seeds, beans and fruits; cottage cheese ; milk beverages, milk predominating; compotes ; fruit-based snack foods ; nut-based snack bars ; seed-based snack bars ; probiotic dairy-based snack bar; powdered milk; frozen, prepared, dried, preserved or packaged meals consisting primarily of meat, fish, poultry, ham, vegetables and game; yogurt-based snack foods; fruit purees
05 - Produits pharmaceutiques, vétérinaires et hygièniques
29 - Viande, produits laitiers et aliments préparés ou conservés
30 - Aliments de base, thé, café, pâtisseries et confiseries
Produits et services
(1) Food for special medical purposes; dietetic foods and substances adapted for medical purposes; food for babies; food for patients and sick persons; infant formula; food for babies with special nutritional needs; non-dairy and plant-based milks for babies, namely milks derived from plants, vegetables, cereals, grains, nuts, seeds, beans and fruits; nutritional products for medical purposes; nutritional supplements; cereals for infants; vitamin preparations; dietetic foods for pregnant, lactating and breast feeding women; dietetic milk for pregnant, lactating and breast feeding women; dietary fiber; protein dietary supplements; soy protein dietary supplements; protein supplements shakes; energy bars used as food supplements; dietary supplements for human beings
(2) Milk and milk products ; yogurt ; milk substitutes ; plant-based milk and milk products, namely milks derived from plants, vegetables, grains, nuts, seeds, beans and fruits; cottage cheese ; milk beverages, milk predominating; compotes ; fruit-based snack foods ; nut-based snack bars ; seed-based snack bars ; probiotic dairy-based snack bar; powdered milk; frozen, prepared, dried, preserved or packaged meals consisting primarily of meat, fish, poultry, ham, vegetables and game; yogurt-based snack foods; fruit purees
67.
A method of assessing weight of an infant and the device thereof
A method performed by an electronic device assessing weight of an infant, obtaining visual information including the infant; obtaining basic information of the infant; determining size information of the infant based on the visual information, the size information comprising at least one of length information of the infant, face information of the infant, pose information of the infant, body shape information of the infant, and chubbiness information of the infant; determining the weight of the infant based on the size information and the basic information.
A61B 5/107 - Mesure de dimensions corporelles, p. ex. la taille du corps entier ou de parties de celui-ci
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
G16H 50/30 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le calcul des indices de santéTIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour l’évaluation des risques pour la santé d’une personne
A card based container has a tubular sidewall of laminate material and first and second end closures, sealed to the tubular sidewall to form a hermetically sealed package. The sidewall has an outer card layer, an inner hygienic layer and one or more sealing strips provided at an inner surface of the inner hygienic layer, located at connection locations where the sidewall seals to itself or to the respective end closures. The sealing strips include a heat-sealable polymer. The overall amount of non-paper content in the sidewall and in the package may thus be reduced.
B65D 53/00 - Éléments d'étanchéité ou d'emballageÉtanchéité réalisée par matériaux liquides ou plastiques
B65D 5/12 - Réceptacles de section transversale polygonale rigides ou semi-rigides, p. ex. boîtes, cartons ou plateaux, formés en pliant ou montant un ou plusieurs flans de papier en pliant ou montant un seul flan pour former un corps tubulaire avec ou sans pliage subséquent, ou par addition d'éléments séparés, pour fermer les extrémités du corps avec les fermetures d'extrémité formées indépendamment du corps tubulaire
B65D 5/56 - Revêtements ou recouvrements intérieurs
The invention relates to a first composition providing at least one of acetic acid or butyric acid for controlling ketosis associated with a ketogenic diet in a subject adhering to a ketogenic diet, wherein controlling ketosis involves a) administering the first composition, b) optionally administering a second composition comprising propionic acid to reduce ketone production/administering a second composition comprising propionic acid provided that blood ketone levels are above 3 mmol/L.
A61K 31/706 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle
A61K 47/36 - PolysaccharidesLeurs dérivés, p. ex. gommes, amidon, alginate, dextrine, acide hyaluronique, chitosane, inuline, agar-agar ou pectine
The invention relates to at least one of C4 or C6 fatty acids and optionally C2 fatty acids for enhancing ketosis associated with a ketogenic diet and/or preventing and/or treating resistance to a ketogenic diet, in a subject adhering to a ketogenic diet, wherein the at least one of C4 or C6 fatty acids and optionally C2 fatty acids are comprised in a non-ketogenic ketogenic diet-booster composition, or the at least C4 or C6 fatty acids and optionally C2 fatty acids are provided in non-ketogenic amounts by a dietary fibre blend comprised in a non-ketogenic ketogenic diet-booster composition.
Provided herein is a nutritional composition having therapeutically effective amounts of a combination of (a) hydrolysed whey protein and (b) MCT for use in (i) reducing tumor growth and/or (ii) for use in improving treatment efficacy in a subject having cancer and undergoing cancer treatment.
A61K 31/23 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine d'acides ayant un groupe carboxyle lié à une chaîne d'au moins sept atomes de carbone
The invention provides a method, system, and computer program product for determining a maturation state of an infant aged between 0 and 120 months, comprising
The invention provides a method, system, and computer program product for determining a maturation state of an infant aged between 0 and 120 months, comprising
measuring at least one microbial biomarker from a set of measurable microbial biomarkers from a faecal sample of the infant,
The invention provides a method, system, and computer program product for determining a maturation state of an infant aged between 0 and 120 months, comprising
measuring at least one microbial biomarker from a set of measurable microbial biomarkers from a faecal sample of the infant,
determining a predicted age of the infant based on the at least one microbial biomarker,
The invention provides a method, system, and computer program product for determining a maturation state of an infant aged between 0 and 120 months, comprising
measuring at least one microbial biomarker from a set of measurable microbial biomarkers from a faecal sample of the infant,
determining a predicted age of the infant based on the at least one microbial biomarker,
wherein
The invention provides a method, system, and computer program product for determining a maturation state of an infant aged between 0 and 120 months, comprising
measuring at least one microbial biomarker from a set of measurable microbial biomarkers from a faecal sample of the infant,
determining a predicted age of the infant based on the at least one microbial biomarker,
wherein
the at least one microbial biomarker is selected from the set of measurable microbial biomarkers based on an analysis of the set of measurable microbial biomarkers as measured in faecal samples from a plurality of vaginally-born breast-fed infants at a plurality of ages,
The invention provides a method, system, and computer program product for determining a maturation state of an infant aged between 0 and 120 months, comprising
measuring at least one microbial biomarker from a set of measurable microbial biomarkers from a faecal sample of the infant,
determining a predicted age of the infant based on the at least one microbial biomarker,
wherein
the at least one microbial biomarker is selected from the set of measurable microbial biomarkers based on an analysis of the set of measurable microbial biomarkers as measured in faecal samples from a plurality of vaginally-born breast-fed infants at a plurality of ages,
the predicted age is obtained based on an evaluation of the at least one measured microbial biomarker using a function based on a plurality of corresponding at least one biomarkers measured in the faecal samples from the plurality of vaginally-born breast-fed infants at the plurality of ages.
G16H 50/30 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le calcul des indices de santéTIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour l’évaluation des risques pour la santé d’une personne
G16B 25/10 - Profilage de l’expression de gènes ou de protéinesEstimation ou normalisation de ratio d’expression
73.
NUTRITIONAL COMPOSITION COMPRISING UREA, NON-DIGESTIBLE OLIGOSACCHARIDE, AND BIFIDOBACTERIA
The invention relates to nutritional compositions for infants and in particular formulae for infants comprising human milk oligosaccharides, specific bifidobacteria, and urea as non-protein nitrogen source for improving the intestinal microbiota.
The invention relates to a nutritional composition comprising a combination of (i) omega-3 fatty acid DHA with (ii) vitamin B2 and (iii) vitamin D3 and one or more from (iv) choline or a salt thereof and/or choline esters; and (v) dietary fibres and/or dietary butyrate for use in the treatment of neurodegenerative diseases and/or neurotrauma, brain injury and/or brain damage. The invention also relates to a composition comprising a combination of DHA, vitamin B2, vitamin D3 with one or more from (iv) choline or a salt thereof and/or choline esters; and (v) dietary fibres and/or dietary butyrate.
A23L 33/21 - Adjonction de substances essentiellement non digestibles, p. ex. de fibres diététiques
A61K 31/202 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p. ex. acides stéarique, palmitique ou arachidique ayant au moins trois doubles liaisons, p. ex. acide linolénique
A61K 31/593 - Dérivés du 9,10-séco-cholestane, p. ex. cholécalciférol, vitamine D3
A61K 31/685 - Diesters d'acide du phosphore avec deux composés hydroxyle, p. ex. phosphatidylinositols un des composés hydroxylés ayant des atomes d'azote, p. ex. phosphatidylsérine, lécithine
A61K 31/714 - Cobalamines, p. ex. cyanocobalamine, vitamine B12
A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p. ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence
A61L 33/00 - Traitement antithrombogénique d'articles chirurgicaux, p. ex. de sutures, cathéters, prothèses ou d'articles pour la manipulation ou le conditionnement du sangMatériaux pour un tel traitement
75.
FERMENTED FORMULA WITH NON DIGESTIBLE OLIGOSACCHARIDES
The present invention relates to a fermented infant or follow on formula comprising non digestible oligosaccharides for decreasing duration of crying, reducing crying episodes, and incidence of colics in infants.
The invention relates to a neuroprotective composition comprising therapeutically effective amounts of a combination of pyruvate and citrate, for the treatment and/or prevention of neuronal damage in a subject suffering from or at risk of seizures.
A61K 31/194 - Acides carboxyliques, p. ex. acide valproïque ayant plusieurs groupes carboxyle, p. ex. acides succinique, maléique ou phtalique
A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
A61K 31/706 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle
A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux
77.
Method and system for characterizing stool patterns of young infants
The invention provides a method of analysing the consistency of stool, including the steps of: providing stool of an infant, capturing, with a portable device comprising a camera, an image of the stool, providing the captured image to an input layer of a pre-trained convolutional neural network, CNN, processing the captured image using the CNN to obtain, from a final layer of the CNN, a classification vector and to obtain information about a predicted score from the classification vector, wherein at least the final layer of the CNN has been customized so that each element of the classification vector corresponds to a score of a stool analysis scale, and storing information about the predicted store.
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
G16H 50/30 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le calcul des indices de santéTIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour l’évaluation des risques pour la santé d’une personne
78.
AMINO ACID METABOLITES FOR ENHANCED DETOXIFICATION ACTIVITY
The invention pertains to a method for increasing and/or improving detoxification capacity comprising increasing AhR activity and/or increasing expression of CYP1A1 in a human subject comprising administering a combination of indole lactic acid (ILA) and imidazole lactic acid (IML), therapeutically effective combinations of ILA and IML for use in improving detoxification and a nutritional composition that comprises ILA and IML for use in improving detoxification.
The present invention relates to a nutritional composition for infants and young children comprising a digestible carbohydrate component, wherein the digestible carbohydrate component comprises a mixture of free galactose and at least one digestible carbohydrate selected from the group consisting of maltodextrin and glucose syrup, and with reduced or no lactose and glucose. The invention also relates to the use of the nutritional composition according to the invention for improving body composition or body composition development.
A23C 9/20 - Produits diététiques à base de lait non couverts par les groupes
A23L 29/30 - Aliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des sirops d'hydrate de carboneAliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des sucresAliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des alcools de sucre, p. ex. du xylitolAliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des hydrolysats d'amidon, p. ex. de la dextrine
A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
The invention relates to a process for dephosphorylation of skim milk, ultra-filtered milk (UF milk) or micellar casein isolate (MCI) comprising (i) acidification of a skim milk, UF milk or MCI preferably not lower than pH 6.0, preferably between 6.0 and 6.7, (ii) cooling the acidified skim milk, UF milk or MCI to the temperature between 0 °C and 15°C, (iii) adding gluconate and/or maleate to the cooled skim milk, UF milk or MCI and, (iv) washing the skim milk, UF milk or MCI, to remove phosphorus, thus dephosphorylating the skim milk, UF milk or MCI, preferably to an extent that the total phosphorous content of the skim milk, UF milk or MCI is reduced with at least 20%, preferably 20-40%, more preferably 30 – 40 % compared to the material provided to step (i). The invention also relates to dephosphorylated MPC, MPI or MCI obtainable by the process of the invention, and to a liquid heat- sterilized enteral nutritional composition comprising 2.0 – 3.0 kcal/ml wherein 16 – 35 en% is provided by protein, the combination of caloric content and relative protein caloric content selected such that there is 10 – 18 g/100 ml protein, preferably 12 – 18 g/100 ml protein in the composition, wherein the protein comprises micellar casein (MC), whey protein (WP) and optionally caseinate (CAS), wherein there is at least 70 wt % MC and less than 15 wt % WP, based on total protein content, and wherein the composition has a total amount of phosphorous less than 192 mg/100 ml and/or 30 – 80 mg/100kcal, preferably at least 30 – 80 mg/100 kcal, most preferably less than 192 mg/100 ml and 30 – 80 mg/100kcal.
A23C 7/04 - Enlèvement du lait des substances indésirables
A23C 9/15 - Produits laitiers reconstitués ou recombinés ne contenant aucune graisse ou protéine autre que celles du lait
A23J 1/20 - Préparation des compositions à base de protéines pour l'alimentationOuverture des œufs par grandes quantités et séparation du jaune du blanc à partir du lait, p. ex. caséinePréparation des compositions à base de protéines pour l'alimentationOuverture des œufs par grandes quantités et séparation du jaune du blanc à partir du petit-lait
The invention relates to a process for dephosphorylation of skim milk, ultra-filtered milk (UF milk) or micellar casein isolate (MCI) comprising (i) acidification of a skim milk, UF milk or MCI preferably not lower than pH 6.0, preferably between 6.0 and 6.7, (ii) cooling the acidified skim milk, UF milk or MCI to the temperature between 0 °C and 15°C, (iii) adding gluconate and/or maleate to the cooled skim milk, UF milk or MCI and, (iv) washing the skim milk, UF milk or MCI, to remove phosphorus, thus dephosphorylating the skim milk, UF milk or MCI, preferably to an extent that the total phosphorous content of the skim milk, UF milk or MCI is reduced with at least 20%, preferably 20-40%, more preferably 30 - 40 % compared to the material provided to step (i). The invention also relates to dephosphorylated skim milk, UF milk or MCI obtainable by the process of the invention, and to a liquid heat-sterilized enteral nutritional composition comprising 2.0 - 3.0 kcal/ml wherein 16 - 35 en % is provided by protein, the combination of caloric content and relative protein caloric content selected such that there is 10 - 18 g/100 ml protein, preferably 12 - 18 g/100 ml protein in the composition, wherein the protein comprises micellar casein (MC), whey protein (WP) and optionally caseinate (CAS), wherein there is at least 70 wt % MC and less than 15 wt % WP, based on total protein content, and wherein the composition has a total amount of phosphorous less than 192 mg/100 ml and/or 30 - 80 mg/100kcal, preferably at least 30 - 80 mg/100 kcal, most preferably less than 192 mg/100 ml and 30 - 80 mg/100kcal.
A23C 7/04 - Enlèvement du lait des substances indésirables
A23C 9/15 - Produits laitiers reconstitués ou recombinés ne contenant aucune graisse ou protéine autre que celles du lait
A23J 1/20 - Préparation des compositions à base de protéines pour l'alimentationOuverture des œufs par grandes quantités et séparation du jaune du blanc à partir du lait, p. ex. caséinePréparation des compositions à base de protéines pour l'alimentationOuverture des œufs par grandes quantités et séparation du jaune du blanc à partir du petit-lait
The present invention concerns a powdered nutritional composition comprising dairy protein and plant-based protein with improved organoleptic properties and flowability, a dry-blending process for obtaining the nutritional composition and a method for providing nutrition to a subject comprising administering the nutritional composition. The nutritional compositions according to the invention have an improved flowability index and improved organoleptic properties.
A23C 9/18 - Lait sous la forme d'un produit comprimé sec ou semi-solide
A23C 11/06 - Succédanés du lait, p. ex. compositions pour remplacer le lait dans le café au lait contenant au moins un composé d'origine non laitière comme source de matières grasses ou de protéines contenant des protéines d'origine non laitière
A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
A23P 10/40 - Fabrication de poudres à écoulement libre ou instantanées, c.-à-d. de poudres reconstituées rapidement par l’ajout d’un liquide
A23L 33/125 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sirops d'hydrate de carboneModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sucresModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des alcools de sucreModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
The present invention relates to a method of fortifying human nutrition with free amide containing amino acids, a method of providing infant nutrition to an infant of a lactating woman that suffers from allergy or of a lactating woman that has suffered from allergy, and supplements or fortified infant formulas comprising free L-glutamine and/or free L-asparagine for use in the treatment or prevention of allergy in infants of a lactating woman that suffers from allergy or of a lactating woman that has suffered from allergy.
A lid structure (10) for a container (40) comprises an annular collar (14) for attachment to the container, having an opening (15) for providing access to an interior (56) of the container. The lid structure further comprises a lid (12) for closing the opening, connected to the collar by a first living hinge. The lid comprises a first lid portion and a second lid portion connected together by a second living hinge which traverses the top surface of the lid and is parallel to the first living hinge. The first lid portion covers the opening. The second lid portion comprises a mating element and the collar comprises a complementary mating element, being configured to engage together to latch the lid to the collar in the closed position of the lid, whereby latching and unlatching of the lid structure is provided by a pivotable motion of the second lid portion about the second living hinge.
B65D 43/16 - Couvercles ou chapeaux inamovibles s'ouvrant à charnières vers le haut ou vers le bas
B65D 43/22 - Dispositifs servant à maintenir en position fermée, p. ex. colliers
B65D 55/16 - Dispositifs empêchant la perte des éléments de fermeture amovibles
85.
METHOD FOR EXPANDING A CYLINDRICAL METALLIC PRECURSOR IN THE MANUFACTURE OF A THREE-PIECE CAN AND SHAPING MANDREL FOR EXPANDING A CYLINDRICAL METALLIC PRECURSOR
A method is described for expanding a cylindrical metallic precursor in the manufacture of a three-piece can. The method comprises the steps of: arranging the precursor, having an initial diameter, around a shaping mandrel, the shaping mandrel having a plurality of longitudinally extending segments disposed radially about a longitudinal axis of the shaping mandrel, the segments having arcuate surfaces for engaging an inner surface of the precursor wall; actuating, in a first step, a first subgroup of the plurality of segments to expand outwards to engage with the inner surface of the precursor wall and expand at least a portion of it to a first diameter that is larger than the initial diameter of the precursor; and actuating, in a second step, a second subgroup of the plurality of segments to expand outwards and also engage with the inner surface of the precursor wall whereby the second subgroup expands at least a portion of the precursor to a second diameter that is larger than the first diameter. The method allows a greater degree of expansion of the wall of a cylindrical metallic container, whereby greater variations in diameter can be achieved between recessed portions and the remainder of the wall.
B21D 51/26 - Fabrication d'objets creux caractérisés par l'usage de l'objet de boîtes de conserve ou bidonsFermeture des boîtes de conserve ou des bidons de façon définitive
B65D 8/00 - Réceptacles de section transversale courbe, dont le corps est formé par jonction ou liaison de plusieurs composants rigides, ou sensiblement rigides, constitués en totalité ou principalement en métal, en matière plastique, en bois ou en un matériau de remplacement
B65D 17/00 - Réceptacles rigides ou semi-rigides spécialement conçus pour être ouverts par coupage ou perçage, ou en perçant ou en déchirant des éléments ou des parties frangibles
METHOD FOR EXPANDING A CYLINDRICAL METALLIC PRECURSOR IN THE MANUFACTURE OF A THREE-PIECE CAN AND SHAPING MANDREL FOR EXPANDING A CYLINDRICAL METALLIC PRECURSOR
A method is described for expanding a cylindrical metallic precursor in the manufacture of a three-piece can. The method comprises the steps of: arranging the precursor, having an initial diameter, around a shaping mandrel, the shaping mandrel having a plurality of longitudinally extending segments disposed radially about a longitudinal axis of the shaping mandrel, the segments having arcuate surfaces for engaging an inner surface of the precursor wall; actuating, in a first step, a first subgroup of the plurality of segments to expand outwards to engage with the inner surface of the precursor wall and expand at least a portion of it to a first diameter that is larger than the initial diameter of the precursor; and actuating, in a second step, a second subgroup of the plurality of segments to expand outwards and also engage with the inner surface of the precursor wall whereby the second subgroup expands at least a portion of the precursor to a second diameter that is larger than the first diameter. The method allows a greater degree of expansion of the wall of a cylindrical metallic container, whereby greater variations in diameter can be achieved between recessed portions and the remainder of the wall.
B21D 51/26 - Fabrication d'objets creux caractérisés par l'usage de l'objet de boîtes de conserve ou bidonsFermeture des boîtes de conserve ou des bidons de façon définitive
A lid structure (10) for a container (40) comprises an annular collar (14) for attachment to the container, having an opening (15) for providing access to an interior (56) of the container. The lid structure further comprises a lid (12) for closing the opening. The lid has an outer periphery (16) and an upper surface (18) with a circumferential ridge (20) located near to but spaced from the outer periphery, whereby a further container having a first base diameter (D1) can stack at an outside of the circumferential ridge. The circumferential ridge has at least two interruptions (22) dividing the circumferential ridge into at least two ridge portions (20A, B) whereby at least two further containers having the first base diameter can stack partially on the lid.
A lid structure (10) for a container (40) comprises an annular collar (14) for attachment to the container, having an opening (15) for providing access to an interior (56) of the container. The lid structure further comprises a lid (12) for closing the opening. The lid has an outer periphery (16) and an upper surface (18) with a circumferential ridge (20) located near to but spaced from the outer periphery, whereby a further container having a base diameter (dr) can stack at an outside of the circumferential ridge. The circumferential ridge has at least two interruptions (22) dividing the circumferential ridge into at least two ridge portions (20A, B) whereby at least two further containers having the same base diameter can stack partially on the lid.
The present invention concerns a powdered nutritional composition comprising intact protein and partially hydrolysed whey protein and a dry-blending process for obtaining the powdered nutritional composition.
A method performed by an electronic device assessing a first nutritional composition, obtaining (201, 301, 401) first visual information of the first nutritional composition; determining (202) whether there is a phase separation of the first nutritional composition based on the first visual information; if it is determined that there is a phase separation, determining (203) properties of at least one layer of the phase separation of the first nutritional composition based on the first visual information.
A23C 9/00 - Préparations à base de laitLait en poudre ou préparations à base de lait en poudre
A23C 13/00 - CrèmePréparations à base de crèmeLeur fabrication
G01N 15/00 - Recherche de caractéristiques de particulesRecherche de la perméabilité, du volume des pores ou de l'aire superficielle effective de matériaux poreux
G01N 33/06 - Détermination de la teneur en graisses, p. ex. par le butyromètre
91.
Mix of specific Bifidobacterium species and specific non-digestible oligosaccharides
A consortium of specific probiotic bacteria comprising Bifidobacterium bifidum and Bifidobacterium breve with specific carbohydrate degrading properties, specific human milk oligosaccharide and preferably also beta-galacto-oligosaccharides with a higher degree of polymerization, is particularly effective for improving intestinal microbiota resilience.
A23L 33/135 - Bactéries ou leurs dérivés, p. ex. probiotiques
A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
A23L 33/125 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sirops d'hydrate de carboneModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sucresModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des alcools de sucreModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
92.
Solid composition suitable as a nutritional composition or supplement for animals that suffer from brain related disorders, decline or diseases
The invention pertains to a solid composition suitable for treating adult animals that suffer from brain-related disorders, brain-related decline or brain-related diseases, preferably suitable for treating adult animals that suffer from brain-related disorders, the composition containing (i) a uridine source, wherein the amount of the sum of all uridine sources, calculated on the basis of the weight of the molar equivalent of uridine monophosphate (UMP), is 0.3-15 g per 100 g dry weight of the composition, (ii) a polyunsaturated fatty acid, preferably an omega-3 polyunsaturated fatty acid, (iii) choline bitartrate, (iv) a buffering salt component, and (v) a milk protein source, wherein the milk protein source is a milk powder, and the buffering salt component containing at least one food approved salt, with a buffering capacity between pH 5-8, the buffering salt component preferably containing a mixture of food-approved salts, or a food-approved salt and its conjugated acid or base.
A61K 31/7072 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle contenant des pyrimidines condensées ou non-condensées ayant des groupes oxo liés directement au cycle pyrimidine, p. ex. cytidine, acide cytidylique ayant deux groupes oxo liés directement au cycle pyrimidine, p. ex. uridine, acide uridylique, thymidine, zidovudine
A61K 31/14 - Composés d'ammonium quaternaire, p. ex. édrophonium, choline
A61K 31/202 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p. ex. acides stéarique, palmitique ou arachidique ayant au moins trois doubles liaisons, p. ex. acide linolénique
The invention pertains to a liquid nutritional composition for use in prevention and/or treatment of whole body protein metabolism decline or whole body protein function decline, or for improving whole body protein metabolism or whole body protein function, particularly for use in muscle decline, or for improving muscle function, in a human subject suffering from metabolic stress and/or starvation, wherein the human subject is preferably a human elderly subject of at least 50 years of age, wherein the composition comprises a protein fraction comprising (a) 15 to 35 weight % of casein; (b) 25 to 50 weight % of whey protein; (c) 10 to 30 weight % of soy protein; and (d) 10 to 30 weight % of pea protein; relative to the total protein in the protein fraction, wherein the sum of said proteins preferably equals 100 weight % of the protein fraction.
A61K 38/17 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains
A61K 38/16 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés
A61P 3/02 - Nutriments, p. ex. vitamines, minéraux
A61P 21/00 - Médicaments pour le traitement des troubles du système musculaire ou neuromusculaire
94.
ELECTRONIC DEVICE AND METHOD FOR DETERMINING HUMAN HEIGHT USING NEURAL NETWORKS
Electronic device for estimating a height of a human, the electronic device comprising: a processor configured to: obtain an image including at least a part of a representation of the human and reference information; input the image to a first neural network and obtain as output from the first neural network first information, the first information related to a plurality of keypoints in the body of the human; input the image to a second neural network and obtain as output from the second neural network second information, the second information related to the reference information; and estimate the height of the human based on the first information and the second information; and an output unit configured to output the estimated height.
The invention concerns a process for preparing an ultrafiltered whey protein hydrolysate comprising tolerogenic peptides wherein an emulsifier and/or a chaotropic agent is added before ultrafiltration. The invention further concerns the product obtainable by the process.
A23C 9/142 - Préparations à base de laitLait en poudre ou préparations à base de lait en poudre dans lesquelles la composition chimique du lait est modifiée par des traitements non chimiques par dialyse, osmose inverse ou ultrafiltration
A23C 21/02 - Petit-laitPréparations à base de petit-lait contenant des micro-organismes ou des enzymes, ou traités à l'aide de ceux-ci
A23C 21/08 - Petit-laitPréparations à base de petit-lait contenant d'autres additifs organiques, p. ex. des produits végétaux ou animaux
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A61K 35/00 - Préparations médicinales contenant des substances ou leurs produits de réaction de constitution non déterminée
A61K 35/744 - Bactéries lactiques, p. ex. entérocoques, pédiocoques, lactocoques, streptocoques ou leuconostoques
A61K 38/17 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains
Provided herein is an enteral ketogenic composition comprising (i) a lipid fraction comprising 45 to 65 g lipids, (ii) a carbohydrate fraction comprising 5 to 12 g digestible carbohydrates, and (iii) a protein fraction comprising 15 - 25 g of protein per 100g of the ketogenic composition, having a ketogenic weight ratio between 1.5:1 and 3.0:1 and therapeutic uses thereof.
A23L 33/125 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sirops d'hydrate de carboneModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sucresModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des alcools de sucreModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
A23L 33/21 - Adjonction de substances essentiellement non digestibles, p. ex. de fibres diététiques
A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
A61K 31/202 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p. ex. acides stéarique, palmitique ou arachidique ayant au moins trois doubles liaisons, p. ex. acide linolénique
A61K 31/23 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine d'acides ayant un groupe carboxyle lié à une chaîne d'au moins sept atomes de carbone
A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p. ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence
A61K 31/14 - Composés d'ammonium quaternaire, p. ex. édrophonium, choline
A61K 31/194 - Acides carboxyliques, p. ex. acide valproïque ayant plusieurs groupes carboxyle, p. ex. acides succinique, maléique ou phtalique
A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
A61K 31/201 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p. ex. acides stéarique, palmitique ou arachidique ayant une ou deux doubles liaisons, p. ex. acides oléique ou linoléique
A61K 31/7004 - Monosaccharides ayant uniquement des atomes de carbone, d'hydrogène et d'oxygène
A61K 31/7016 - Disaccharides, p. ex. lactose, lactulose
A61K 31/706 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle
A61K 31/715 - Polysaccharides, c.-à-d. ayant plus de cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiquesLeurs dérivés, p. ex. éthers, esters
The present invention concerns nutritional compositions for infants and young children that are high in oleic acid and low in palmitic acid and comprise galacto-oligosaccharides, in particular including beta1,3′-galactosyllactose. The nutritional compositions are particularly advantageous for improving intestinal barrier function.
A61K 31/201 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p. ex. acides stéarique, palmitique ou arachidique ayant une ou deux doubles liaisons, p. ex. acides oléique ou linoléique
A61P 1/00 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif
05 - Produits pharmaceutiques, vétérinaires et hygièniques
29 - Viande, produits laitiers et aliments préparés ou conservés
Produits et services
Dietetic foods adapted for medical use; dietetic foods and beverages adapted for medical purposes; food for babies; food for patients and sick persons namely dietetic foods adapted for medical purposes; infant formula; food for babies with special nutritional needs; non-dairy and plant-based milks for babies, namely milks derived from plants, vegetables, cereals, grains, nuts, seeds, beans and fruits namely infant formula; nutritional products for medical purposes namely nutritionally fortified beverages for medical purposes; nutritional supplements; cereals for infants; vitamin preparations; dietetic foods adapted for medical use, namely for pregnant, lactating and breast feeding women; dietetic milk for pregnant, lactating and breast feeding women; dietary fiber to aid digestion; protein dietary supplements; soy protein dietary supplements; protein supplements shakes; nutritional supplement energy bars; dietary supplements for human beings Milk and milk products, excluding ice cream, ice milk and frozen yogurt; yogurt; milk substitutes; plant-based milk substitutes and milk products, excluding ice cream, ice milk and frozen yogurt, namely milks derived from plants, vegetables, grains, nuts, seeds, beans and fruits namely, plant-based milk substitutes and nut milk-based beverages; cottage cheese; milk beverages, milk predominating; compotes; fruit-based snack foods; nut-based snack bars; seed-based snack bars; probiotic dairy-based snack bar, namely cheese-based snack bars; powdered milk; frozen, prepared, dried, preserved or packaged meals consisting primarily of meat, fish, poultry, ham, vegetables and game; yogurt-based snack foods; fruit purees
99.
NUTRITIONAL COMPOSITION FOR MUSCLE MASS, STRENGTH AND FUNCTION
The invention pertains to a nutritional composition for use in prevention and/or treatment of whole body protein metabolism decline or whole body protein function decline, or for therapeutic use in improving whole body protein metabolism or whole body protein function, in a human subject, wherein the human subject is preferably an ageing human elderly subject of at least 40 years of age, wherein the composition comprises a protein fraction comprising 32-58 wt % pea protein, 30-56 wt % soy protein and 8-16 wt % free leucine, preferably a protein fraction comprising 36-54 wt % pea protein, 34-52 wt % soy protein and 10-14 wt % free leucine, and optionally up to 5 wt % of free branched chain amino acids other than leucine, based on all proteinaceous matter, wherein the composition is essentially free from animal protein.
The present invention relates to a use of octenylsuccinyl anhydride substituted starch (OSA starch) for increasing the dry weight content and/or the fat content of a liquid composition that is subjected to a spray-drying step, and also to a process for preparing powders. The present invention enables the spray-drying of emulsions that contain a high amount of fat. The present invention also relates to the powder products obtainable by the process and nutritional products such as an infant milk powder, grow up milk, toddler milk or as a medical nutritional product that can be formulated therewith.
A23L 33/115 - Acides gras ou leurs dérivésGraisses ou huiles
A23L 29/219 - Amidon chimiquement modifiéProduits de réaction ou de complexation de l’amidon avec d’autres produits chimiques
A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
A23L 33/125 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sirops d'hydrate de carboneModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sucresModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des alcools de sucreModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
A23P 10/47 - Fabrication de poudres à écoulement libre ou instantanées, c.-à-d. de poudres reconstituées rapidement par l’ajout d’un liquide utilisant des additifs, p. ex. des émulsifiants, des agents mouillants ou des agents liant la poussière
A61K 31/202 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p. ex. acides stéarique, palmitique ou arachidique ayant au moins trois doubles liaisons, p. ex. acide linolénique
A61K 47/36 - PolysaccharidesLeurs dérivés, p. ex. gommes, amidon, alginate, dextrine, acide hyaluronique, chitosane, inuline, agar-agar ou pectine
A61K 47/44 - Huiles, graisses ou cires couvertes par plus d’un des groupes Huiles, graisses ou cires naturelles ou naturelles modifiées, p. ex. huile de ricin, huile de ricin polyéthoxylée, cire de lignite, lignite, gomme-laque, colophane, cire d’abeille ou lanoline
